| 1273 | The mRNA-based Spikevax vaccine (by Moderna) |
| Ab | Antibodies |
| Ad | Adenovirus |
| Ad26.COV2-S | The single shot DNA vaccine by Janssen Biontech |
| ARDs | Autoimmune rheumatic Diseases |
| AZD122 | The ChAdOx1 DNA-vectored AstraZeneca vaccine |
| BBIBP-CorV | The Sinopharm subunit inactivated vaccine |
| BMI | Body mass index |
| BNT162b2 | Comirnatry (the Pfitzer mRNA Vaccine) |
| cART | Combination antiretroviral therapy |
| CoronaVac | The Sinovac subunit inactivated vaccine |
| GVHD | Graft-versus-host disease (GVHD), |
| HCs | Healthy controls |
| HCW | Health care workers |
| HSCT | Allogenic hematopoietic stem cell transplantation |
| NAb | Neutralizing antibodies |
| PLWH | Patients living with HIV |
| RBD | Receptor-binding-domain |
| S-RBD-IgG | Anti Spike receptor binding domain-specific IgG Antibodies |